AccuraGen: George Cardoza
George Cardoza has been appointed as CEO of liquid biopsy firm AccuraGen and will join the firm’s board of directors. He succeeds CEO and Cofounder Kang Ying, who will remain chairman of the board. Cardoza previously served as CFO, president of the pharma services division, chief operating officer, and president of laboratory operations at NeoGenomics. Before that, he spent more than 14 years at Quest Diagnostics.